These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11118161)

  • 21. Molecular screening for familial hypercholesterolaemia: consequences for life and disability insurance.
    Homsma SJ; Huijgen R; Middeldorp S; Sijbrands EJ; Kastelein JJ
    Eur J Hum Genet; 2008 Jan; 16(1):14-7. PubMed ID: 17957228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial hypercholesterolaemia: genetic testing in general practice and beyond.
    Brett T; Watts GF
    Heart; 2021 Dec; 107(24):1928-1930. PubMed ID: 34686565
    [No Abstract]   [Full Text] [Related]  

  • 23. Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategies.
    Martin AC; Bell DA; Brett T; Watts GF
    Curr Opin Lipidol; 2017 Aug; 28(4):321-327. PubMed ID: 28426524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial hypercholesterolaemia--screening is effective, but is it cost effective?
    Fox KF
    Eur Heart J; 2002 Dec; 23(24):1892-3. PubMed ID: 12473248
    [No Abstract]   [Full Text] [Related]  

  • 25. Follow up after a family based genetic screening programme for familial hypercholesterolaemia: is screening alone enough?
    Van Maarle MC; Stouthard ME; Marang-Van De Mheen PJ; Klazinga NS; Bonsel GJ
    BMJ; 2002 Jun; 324(7350):1367-8. PubMed ID: 12052805
    [No Abstract]   [Full Text] [Related]  

  • 26. High specificity makes DNA screening the method of choice for diagnosis of familial hypercholesterolaemia.
    Kotze MJ
    S Afr Med J; 2001 Dec; 91(12):1042. PubMed ID: 11845598
    [No Abstract]   [Full Text] [Related]  

  • 27. Genetic testing for familial hypercholesterolaemia: utility beyond diagnosis.
    Bigossi M; Siddiqui MK
    Eur J Prev Cardiol; 2024 May; 31(7):e59-e61. PubMed ID: 36356117
    [No Abstract]   [Full Text] [Related]  

  • 28. Universal screening of children for familial hypercholesterolaemia: Value for money?
    Ademi Z; Martin AC
    Atherosclerosis; 2018 Aug; 275():384-386. PubMed ID: 29961599
    [No Abstract]   [Full Text] [Related]  

  • 29. Familial hypercholesterolaemia: Child-parent screening may have adverse psychological effects.
    Hopcroft KA
    BMJ; 2007 Oct; 335(7622):683. PubMed ID: 17916819
    [No Abstract]   [Full Text] [Related]  

  • 30. Familial hypercholesterolaemia: Cascade testing is tried and tested and cost effective.
    Hadfield GS; Humphries SE
    BMJ; 2007 Oct; 335(7622):683. PubMed ID: 17916820
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular testing for familial hypercholesterolaemia-associated mutations in a UK-based cohort: development of an NGS-based method and comparison with multiplex polymerase chain reaction and oligonucleotide arrays.
    Reiman A; Pandey S; Lloyd KL; Dyer N; Khan M; Crockard M; Latten MJ; Watson TL; Cree IA; Grammatopoulos DK
    Ann Clin Biochem; 2016 Nov; 53(6):654-662. PubMed ID: 26748104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular diagnosis of familial hypercholesterolaemia.
    Graham CA; Latten MJ; Hart PJ
    Curr Opin Lipidol; 2017 Aug; 28(4):313-320. PubMed ID: 28463860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.
    Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF
    Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Genetic screening and treatment in familial hypercholesterolemia].
    Leren TP; Tonstad S; Ose L
    Tidsskr Nor Laegeforen; 2001 May; 121(13):1635-6. PubMed ID: 11446055
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.
    Haralambos K; Whatley SD; Edwards R; Gingell R; Townsend D; Ashfield-Watt P; Lansberg P; Datta DB; McDowell IF
    Atherosclerosis; 2015 May; 240(1):190-6. PubMed ID: 25797312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementation of cascade testing for the detection of familial hypercholesterolaemia.
    Hadfield SG; Humphries SE
    Curr Opin Lipidol; 2005 Aug; 16(4):428-33. PubMed ID: 15990592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How disturbing is it to be approached for a genetic cascade screening programme for familial hypercholesterolaemia? Psychological impact and screenees' views.
    van Maarle MC; Stouthard ME; Marang-van de Mheen PJ; Klazinga NS; Bonsel GJ
    Community Genet; 2001; 4(4):244-52. PubMed ID: 12751487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands.
    Umans-Eckenhausen MA; Defesche JC; Sijbrands EJ; Scheerder RL; Kastelein JJ
    Lancet; 2001 Jan; 357(9251):165-8. PubMed ID: 11213091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia.
    Minhas R; Humphries SE; Qureshi N; Neil HA;
    Heart; 2009 Apr; 95(7):584-7; discussion 587-91. PubMed ID: 19168470
    [No Abstract]   [Full Text] [Related]  

  • 40. Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemia.
    Datta BN; McDowell IF; Rees A
    Curr Opin Lipidol; 2010 Aug; 21(4):366-71. PubMed ID: 20613514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.